Source: Contract Pharma

Fujifilm Irvine Scientific: Fujifilm Irvine Scientific Launches BalanCD HEK293 Viral Feed

Designed to boost adeno-associated viral vector (AAV) production for gene therapy applications and viral vector-based vaccines.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
250-500
Yutaka Yamaguchi's photo - President & CEO of Fujifilm Irvine Scientific

President & CEO

Yutaka Yamaguchi

CEO Approval Rating

86/100

Read more